Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 4, 2006, Pages 1357-1363

  Lo, Joan C ^a,b   Feigenbaum, Seth L ^b,d   Yang, Jingrong ^a   Pressman, Alice R ^a   Selby, Joe V ^a   Go, Alan S ^a,c  

^a DIVISION OF RESEARCH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d KAISER PERMANENTE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DATA BASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; HEALTH CARE SYSTEM; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; OVARY POLYCYSTIC DISEASE; PREVALENCE; PRIORITY JOURNAL; BODY MASS; CARDIOVASCULAR DISEASE; FACTUAL DATABASE; OBESITY; RISK ASSESSMENT; UNITED STATES;

ADULT; BODY MASS INDEX; CALIFORNIA; CARDIOVASCULAR DISEASES; DATABASES, FACTUAL; DIABETES MELLITUS; DYSLIPIDEMIAS; FEMALE; HUMANS; HYPERTENSION; OBESITY; POLYCYSTIC OVARY SYNDROME; RISK ASSESSMENT;

EID: 33646026735     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2005-2430     Document Type: Article

References (28)

1. Franks S 1995 Polycystic ovary syndrome. N Engl J Med 333:853-861
2. Sam S, Dunaif A 2003 Polycystic ovary syndrome: syndrome XX? Trends Endocrinol Metab 14:365-370
3. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R 1998 Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 83:3078-3082
4. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO 2004 The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 89:2745-2749
5. Diamanti-Kandarakis E, Kouli CR, Bergiele AT, Filandra FA, Tsianateli TC, Spina GG, Zapanti ED, Bartzis MI 1999 A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 84:4006-4011
6. Asuncion M, Calvo RM, San Millan JL, Sancho J, Avila S, Escobar-Morreale HF 2000 A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 85:2434-2438
7. Dunaif A 1997 Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 18:774-800
8. Legro RS, Kunselman AR, Dodson WC, Dunaif A 1999 Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 84:165-169
9. Palmert MR, Gordon CM, Kartashov AI, Legro RS, Emans SJ, Dunaif A 2002 Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome. J Clin Endocrinol Metab 87:1017-1023
10. Solomon CG, Hu FB, Dunaif A, Rich-Edwards J, Willett WC, Hunter DJ, Colditz GA, Speizer FE, Manson JE 2001 Long or highly irregular menstrual cycles as a marker for risk of type 2 diabetes mellitus. JAMA 286:2421-2426
11. Legro RS, Kunselman AR, Dunaif A 2001 Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome. Am J Med 111:607- 613
12. Apridonidze T, Essah PA, Iuorno MJ, Nestler JE 2005 Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 90:1929-1935
13. Legro RS, Urbanek M, Kunselman AR, Leiby BE, Dunaif A 2002 Self-selected women with polycystic ovary syndrome are reproductively and metabolically abnormal and undertreated. Fertil Steril 78:51-57
14. Talbott EO, Zborowski JV, Rager JR, Boudreaux MY, Edmundowicz DA, Guzick DS 2004 Evidence for an association between metabolic cardiovascular syndrome and coronary and aortic calcification among women with polycystic ovary syndrome. J Clin Endocrinol Metab 89:5454-5461
15. Christian RC, Dumesic DA, Behrenbeck T, Oberg AL, Sheedy 2nd PF, Fitzpatrick LA 2003 Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome. J Clin Endocrinol Metab 88:2562-2568
16. Ehrmann DA 2005 Polycystic ovary syndrome. N Engl J Med 352:1223-1236
17. Guzick DS, Talbott EO, Sutton-Tyrrell K, Herzog HC, Kuller LH, Wolfson Jr SK 1996 Carotid atherosclerosis in women with polycystic ovary syndrome: initial results from a case-control study. Am J Obstet Gynecol 174:1224-1229; discussion 1229-1232
18. Kelly CJ, Speirs A, Gould GW, Petrie JR, Lyall H, Connell JM 2002 Altered vascular function in young women with polycystic ovary syndrome. J Clin Endocrinol Metab 87:742-746
19. Krieger N 1992 Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. Am J Public Health 82:703-710
20. Selby JV, Ray GT, Zhang D, Colby CJ 1997 Excess costs of medical care for patients with diabetes in a managed care population. Diabetes Care 20:1396-1402
21. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY 2004 Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351:1296-1305
22. 2001 Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (adult treatment panel III). JAMA 285:2486-2497
23. National Institutes of Health 1998 Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. NIH Pub. No. 98-4083. Bethesda, MD: NIH; 62
24. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL, Jones DW, Materson BJ, Oparil S, Wright Jr JT, Roccella EJ 2003 The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289:2560-2572
25. WHO Expert Consultation 2004 Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363:157-163
26. Balen A, Michelmore K 2002 What is polycystic ovary syndrome? Are national views important? Hum Reprod 17:2219-2227
27. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group 2004 Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81:19-25
28. Chang JR 2002 Polycystic ovary syndrome: diagnostic criteria. In: Chang JR, Heindel JJ, Dunaif A, eds. Polycystic ovary syndrome. New York: Marcel Dekker, Inc.; 361-365.